Clinical use of psychotherapeutic drugs: current status.
D000437:Alcoholism / Q000188:drug therapy; D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D001463:Barbiturates / Q000627:therapeutic use; D001519:Behavior / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy; D002188:Cannabis / Q000627:therapeutic use; D002707:Chlordiazepoxide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003704:Dementia / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy*; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use; D008620:Meprobamate / Q000627:therapeutic use; D008996:Monoamine Oxidase Inhibitors; D009536:Niacinamide / Q000627:therapeutic use; D009661:Nortriptyline / Q000627:therapeutic use; D010076:Oxazepam / Q000627:therapeutic use; D010640:Phenothiazines; D008517:Phytotherapy; D010919:Placebos; D011346:Prochlorperazine / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000188:drug therapy*; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D001463:Barbiturates; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D010919:Placebos; D014149:Tranquilizing Agents; D000639:Amitriptyline; D009536:Niacinamide; D010076:Oxazepam; D002707:Chlordiazepoxide; D008238:Lysergic Acid Diethylamide; D008094:Lithium; D008620:Meprobamate; D009661:Nortriptyline; D013881:Thioridazine; D007099:Imipramine; D003975:Diazepam; D011346:Prochlorperazine